The identification of novel biomarkers is required to improve adult SMA patient stratification, diagnosis and treatment

P Smeriglio, P Langard, G Querin, MG Biferi - Journal of personalized …, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is currently classified into five different subtypes, from the
most severe (type 0) to the mildest (type 4) depending on age at onset, best motor function …

Understanding epigenetic architecture of suicide neurobiology: A critical perspective

B Roy, Y Dwivedi - Neuroscience & Biobehavioral Reviews, 2017 - Elsevier
Current understanding of environmental cross-talk with genetic makeup is found to be
mediated through an epigenetic interface which is associated with prominent reversible and …

Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype

C Ruhno, VL McGovern, MR Avenarius, PJ Snyder… - Human genetics, 2019 - Springer
Spinal muscular atrophy (SMA) is a progressive motor neuron disease caused by loss or
mutation of the survival motor neuron 1 (SMN1) gene and retention of SMN2. We performed …

The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy

M Costa-Roger, L Blasco-Pérez, I Cuscó… - International Journal of …, 2021 - mdpi.com
After 26 years of discovery of the determinant survival motor neuron 1 and the modifier
survival motor neuron 2 genes (SMN1 and SMN2, respectively), three SMN-dependent …

Identifying biomarkers of spinal muscular atrophy for further development

J Glascock, BT Darras, TO Crawford… - Journal of …, 2023 - content.iospress.com
Background: Spinal muscular atrophy (SMA) is caused by bi-allelic, recessive mutations of
the survival motor neuron 1 (SMN1) gene and reduced expression levels of the survival …

Molecular factors involved in spinal muscular atrophy pathways as possible disease-modifying candidates

MA Maretina, GY Zheleznyakova, KM Lanko… - Current …, 2018 - ingentaconnect.com
Spinal Muscular Atrophy (SMA) is a neuromuscular disorder caused by mutations in the
SMN1 gene. Being a monogenic disease, it is characterized by high clinical heterogeneity …

Epigenetics of neuromuscular disorders

F Coppedè - Epigenomics, 2020 - Taylor & Francis
Neuromuscular disorders are a heterogeneous group of conditions affecting the
neuromuscular system. The aim of this article is to review the major epigenetic findings in …

[HTML][HTML] Genome-wide 5-hydroxymethylcytosine patterns in human spermatogenesis are associated with semen quality

OA Efimova, AA Pendina, AV Tikhonov, SE Parfenyev… - Oncotarget, 2017 - ncbi.nlm.nih.gov
We performed immunofluorescent analysis of DNA hydroxymethylation and methylation in
human testicular spermatogenic cells from azoospermic patients and ejaculated …

Identification of specific gene methylation patterns during motor neuron differentiation from spinal muscular atrophy patient-derived iPSC

MA Maretina, KR Valetdinova, NA Tsyganova… - Gene, 2022 - Elsevier
Spinal muscular atrophy is a progressive motor neuron disorder caused by deletions or
point mutations in the SMN1 gene. It is not known why motor neurons are particularly …

Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg

A Kiselev, M Maretina, S Shtykalova, H Al-Hilal… - International Journal of …, 2024 - mdpi.com
Spinal muscular atrophy 5q (SMA) is one of the most common neuromuscular inherited
diseases and is the most common genetic cause of infant mortality. SMA is associated with …